Medicine & Health

More investment is needed in research, funding and policy to improve the collection and analyses of disaggregated health data for the growing and diverse U.S. Latino population, finds a new report from the Brown School at Washington University in St. Louis.

Research led by the School of Medicine found that community outreach and education are critical for individuals navigating health insurance options available in the Affordable Care Act (ACA) marketplace. Such efforts at the state level may have contributed to a higher enrollment among Missourians in 2018.

People with depression who are treated with nerve stimulation experience significant improvements in quality of life, even when their depression symptoms don’t completely subside, according to results of a national study led by School of Medicine researchers.

School of Medicine researchers are trying a different approach to alleviate depression. Using CRISPR technology, the scientists have been able to target a different type of receptor in the brain that may be aided by natural mood-boosting substances.

Rachel Tabak, research associate professor at the Brown School, has received a five-year $3.3 million grant from the National Institutes of Health to study ways to prevent weight gain and chronic disease among mothers age 18-35.

Inducing labor in healthy first-time mothers in the 39th week of pregnancy results in lower rates of cesarean sections compared with waiting for labor to begin naturally at full term, according to a multicenter study that involved the School of Medicine and was funded by the National Institutes of Health (NIH).

Researchers at the School of Medicine have uncovered new details in how a tissue called the olfactory epithelium develops in the nasal cavity. The findings could shed new light on why dogs have such a good sense of smell.

A new School of Medicine study shows that children born with neurofibromatosis (NF1), a common genetic syndrome, are much more likely to have brain tumors than previously thought.

The School of Medicine has joined with Mallinckrodt Pharmaceuticals in a collaborative research partnership aimed at pursuing new therapies for patients with complex medical conditions, especially rare diseases that may have few or no treatment options. The global pharmaceutical company will fund up to $10 million over five years.

Researchers at Washington University School of Medicine are leading a national, multicenter study exploring whether testosterone plus exercise can restore physical abilities in elderly women who have broken a hip. The study is funded with a $15.6 million National Institutes of Health (NIH) grant.